Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Jiang Long

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-6048-0737; OpenAlex author ID A5103918734. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2015: 3 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. AK112 (PD-1/VEGF-a bispecific antibody) combined with chemotherapy in locally advanced pancreatic cancer: a case report. Last author DOI 10.3389/fonc.2025.1667445↗
  2. Pancreatic cancer: BRCA mutation and personalized treatment. Co-author DOI 10.1586/14737140.2015.1086271↗
  3. Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer. Co-author DOI 10.2147/dddt.s77597↗
  4. U0126 inhibits pancreatic cancer progression via the KRAS signaling pathway in a zebrafish xenotransplantation model. Co-author DOI 10.3892/or.2015.4019↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiuliang Yan · 1 shared paper, 2025 · strength 0.26
  2. Chuntao Wu · 1 shared paper, 2025 · strength 0.26
  3. Haitao Gu · 1 shared paper, 2025 · strength 0.26
  4. Meng Guo · 2 shared papers, 2015 · strength 0.11
  5. Quanxing Ni · 2 shared papers, 2015 · strength 0.10
  6. Xianjun Yu · 2 shared papers, 2015 · strength 0.10
  7. Chen Liu · 2 shared papers, 2015 · strength 0.10
  8. Guopei Luo · 2 shared papers, 2015 · strength 0.10
  9. Kaizhou Jin · 2 shared papers, 2015 · strength 0.10
  10. Xu Wang · 1 shared paper, 2015 · strength 0.06
  11. Cheng He · 1 shared paper, 2015 · strength 0.05
  12. Zhiwen Xiao · 1 shared paper, 2015 · strength 0.05
  13. Jin Xu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.